1000001571

Cohance Lifesciences

399.60
-18.05 (-4.32%) tick NSE

Last updated on 20 Jan 2026 11:39 PM

Returns
-12.77%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

15951.14

Earning Per Share

8.19

Dividend Yield

-%

P/E Ratio

50.91

P/B Ratio

4.21

Debt to Equity

0.12

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated on November 6, 2018. The name of the Company has been changed to Cohance Lifesciences Limited w.e.f. May 7, 2025. Cohance Lifesciences Ltd is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors. The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations.

Similar Companies